Literature DB >> 10653569

Candida dubliniensis fungemia: the first four cases in North America.

M E Brandt1, L H Harrison, M Pass, A N Sofair, S Huie, R K Li, C J Morrison, D W Warnock, R A Hajjeh.   

Abstract

We report the first four North American cases of Candida dubliniensis fungemia, including the first isolation of this organism from the bloodstream of an HIV-infected person. All isolates were susceptible in vitro to commonly used antifungal drugs. This report demonstrates that C. dubliniensis can cause bloodstream infection; however, the incidence of disease is not known.

Entities:  

Mesh：

Year:  2000        PMID： 10653569      PMCID： PMC2627985          DOI： 10.3201/eid0601.000108

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  5 in total

1.  Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States.

Authors:  I F Salkin; W R Pruitt; A A Padhye; D Sullivan; D Coleman; D H Pincus
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

Review 2.  The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside.

Authors:  G T Cole; A A Halawa; E J Anaissie
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

3.  A novel group I intron in Candida dubliniensis is homologous to a Candida albicans intron.

Authors:  H Boucher; S Mercure; S Montplaisir; G Lemay
Journal:  Gene       Date:  1996-11-21       Impact factor: 3.688

4.  Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation.

Authors:  J F Meis; M Ruhnke; B E De Pauw; F C Odds; W Siegert; P E Verweij
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

5.  Rapid identification of Candida species with species-specific DNA probes.

Authors:  C M Elie; T J Lott; E Reiss; C J Morrison
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948
  5 in total
  36 in total

1.  First report of Candida dubliniensis in the Middle East.

Authors:  D A Stevens
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  One-year prevalence of Candida dublinienis in a Dutch university hospital.

Authors:  J F Meis; F M Lunel; P E Verweij; A Voss
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

Review 3.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

4.  Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.

Authors:  Carolina Rodrigues Costa; Janine Aquino de Lemos; Xisto Sena Passos; Crystiane Rodrigues de Araújo; Ana Joaquina Cohen; Lúcia Kioko Hasimoto E Souza; Maria do Rosário Rodrigues Silva
Journal:  Mycopathologia       Date:  2006-07       Impact factor: 2.574

5.  8th ASM conference on Candida and candidiasis: molecular tools provide insights into host-pathogen interactions.

Authors:  Gary P Moran; Mary Ann Jabra-Rizk
Journal:  Mycopathologia       Date:  2006-07       Impact factor: 2.574

6.  Prevalence of Candida dubliniensis fungemia in Argentina: identification by a novel multiplex PCR and comparison of different phenotypic methods.

Authors:  Maria Eugenia Bosco-Borgeat; Constanza Giselle Taverna; Susana Cordoba; Maria Guillermina Isla; Omar Alejandro Murisengo; Wanda Szusz; Walter Vivot; Graciela Davel
Journal:  Mycopathologia       Date:  2011-07-13       Impact factor: 2.574

7.  Candida dubliniensis at a university hospital in Saudi Arabia.

Authors:  R Fotedar; S S A Al-Hedaithy
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Candida dubliniensis infections in a pediatric population: retrospective identification from clinical laboratory isolates of Candida albicans.

Authors:  Jean O Kim; Lucille Garofalo; Deborah Blecker-Shelly; Karin L McGowan
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.

Authors:  Rana A Hajjeh; Andre N Sofair; Lee H Harrison; G Marshall Lyon; Beth A Arthington-Skaggs; Sara A Mirza; Maureen Phelan; Juliette Morgan; Wendy Lee-Yang; Meral A Ciblak; Lynette E Benjamin; Laurie Thomson Sanza; Sharon Huie; Siew Fah Yeo; Mary E Brandt; David W Warnock
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland.

Authors:  Lena Rós Asmundsdóttir; Helga Erlendsdóttir; Magnús Gottfredsson
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.